How much is Locus Biosciences worth in 2026?

Locus Biosciences has a current valuation of N/A based on their Later Stage VC (Series B) round and secondary market data.

How much funding has Locus Biosciences raised?

Locus Biosciences has raised N/A in total funding across 1 funding rounds.

Locus Biosciences

Biotechnology

Locus Biosciences valuation and funding history | Last updated: May 18, 2022 | 1 funding rounds

Current Valuation

N/A

As of May 18, 2022

Total Funding Raised

N/A

Across 1 round

Last Round

Later Stage VC (Series B)

$35.0M

Last Funding

May 2022

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
May 18, 2022	Later Stage VC (Series B)	$35.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Locus Biosciences is currently valued at N/A as of May 18, 2022.

Track Locus Biosciences Valuation Updates

Get notified when Locus Biosciences raises new funding or valuation changes

Explore More Data

Detailed analysis for Locus Biosciences

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Locus Biosciences's valuation history, funding rounds, and growth metrics.

No credit card required

What is Locus Biosciences Worth in 2026?

Locus Biosciences is a leading private company in the Biotechnology sector. Track Locus Biosciences's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Locus Biosciences Valuation is Determined

Private company valuations like Locus Biosciences's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.